Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0338671 (Steroids)
 9,479 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A sensitive accurate assay for the placental microsomal 3 beta-hydroxysteroid dehydrogenase (E.C.1.1.1.51) has been developed using tritiated substrates. Kinetic analysis of the enzyme with 3 beta-hydroxy-5-androsten-17-one and 3 beta-hydroxy-5-pregnen-20-one indicates that the apparent Km values for these substrates are orders of magnitude less than previously described. Analyses were carried out with microsomal preparations from two different placentas. For placenta 1 the apparent Km value for 3 beta-hydroxy-5-androsten-17-one was 14 nM and for 3 beta-hydroxy-5-pregnen-20-one was 36 nM; for placental 2 apparent Km values were 19 nM and 42 nM respectively. The analyses were performed over wide ranges of substrate concentration (about 200 fold), both above and below the Km values and no deviation from linearity of Eadie-Hoftsee plots was observed.
Steroids 1979 Apr
PMID:Kinetic analysis of the placental microsomal 3 beta-hydroxysteroid dehydrogenase activity. 15

Key to the production of biologically active steroids is the enzyme 3 beta-hydroxysteroid dehydrogenase-isomerase. Some controversy has arisen concerning the subcellular distribution of this enzyme within steroidogenic cells. The distribution of 3 beta-hydroxysteroid dehydrogenase-isomerase was assessed in subcellular fractions obtained from homogenates of rat, bovine, and mouse adrenal glands in two ways. The activity of 3 beta-hydroxysteroid dehydrogenase-isomerase was quantitated by measuring the conversion of radiolabeled pregnenolone to radiolabeled progesterone in an aliquot of each of the fractions obtained. The presence of the enzyme was assessed by performing Western analyses on aliquots of each of the fractions obtained with the use of a specific polyclonal antiserum against 3 beta-hydroxysteroid dehydrogenase-isomerase, the characterization of which is described. In control experiments, the degree of contamination of the fractions was determined by assessing the presence of known subcellular fraction markers with Western analysis. In the bovine and mouse adrenal glands, 3 beta-hydroxysteroid dehydrogenase-isomerase appears to be localized solely in the microsomal fraction, while in the rat, 3 beta-hydroxysteroid dehydrogenase-isomerase appears to have dual subcellular distribution: the microsomes and the inner mitochondrial membrane. We conclude that there is a species difference in the subcellular distribution of this important steroidogenic enzyme and that this species difference may be related to the steroidogenic pathway preferred in that species.
Steroids 1991 Jun
PMID:Subcellular distribution of 3 beta-hydroxysteroid dehydrogenase-isomerase in bovine and murine adrenocortical tissue: species differences in the localization of activity and immunoreactivity. 192 30

In all subcellular pituitary fractions, 3 alpha-hydroxysteroid dehydrogenase (3 alpha-ol dehydrogenase) activity is high (1 to 3 pmol/mg/h) with NADH or NADPH as cofactor, and 3 beta-hydroxysteroid dehydrogenase (3 beta-ol dehydrogenase) activity much lower. The highest activity of the latter (0.15 pmol/mg/h) is detected in cytosol with NADH as cofactor. During sexual maturation, cytosolic (NADH-dependent) 3 alpha- and 3 beta-ol dehydrogenase activities remain constant, whereas the 5 alpha-reductase activity is maximum at 37 days. The levels of different pituitary androgens were evaluated by radioimmunoassay. At 28 days, testosterone level is 4 ng/g of tissue, then after 42 days the level remains between 4.5 and 6 ng/g at a level higher than the DHT level. In all cases during the maturation of the rat, the different 5 alpha-reduced androgens are in the same ratio: DHT greater than 3 alpha-diol greater than 3 beta-diol, and the sum of these three 5 alpha-reduced androgens decreases between the 28th and the 90th day.
Steroids 1989 Jun
PMID:The activity of 3 alpha- and 3 beta-hydroxysteroid dehydrogenases and 5 alpha-reductase, together with androgen levels in male rat pituitary during sexual maturation. 281 53

The effect of alterations of the steroid nucleus on its potency to induce germinal vesicle breakdown (GVBD) of Atlantic croaker oocytes in vitro was investigated. The addition of 17 alpha-, 20 beta-, or 21-hydroxyl groups to the progesterone steroid nucleus enhanced steroid potency to induce GVBD. Whereas the 20 beta-hydroxyl group on the side chain was the most potent single alteration of the progesterone nucleus, the 17 alpha-hydroxyl group seemed to be vital for establishing the proper steric orientation of the side chain. The most potent steroids to induce GVBD contained either the 17 alpha,20 beta-dihydroxy or the 17 alpha,20 beta,21-trihydroxy configuration. Steroids of the 3-keto-delta 4 and the 3 beta-hydroxy-delta 5 configuration had similar potency. In addition, the 3 beta-hydroxysteroid dehydrogenase inhibitor, cyanoketone, did not affect human chorionic gonadotropin-induced GVBD. However, other alterations of the A and B rings of the steroid nucleus resulted in diminished potency (3 alpha-hydroxy, 5 alpha, and 5 beta configurations). Addition of hydroxyl groups at the 11 beta, 16 alpha, or 20 alpha positions resulted in steroids with reduced potency. The low potency of steroids lacking the side chain (estrogens and androgens) and steroids with the side chain in the 17 alpha position (progestin analogs) is further evidence that the side chain configuration is important for biological activity. Human chorionic gonadotropin and other gonadotropin preparations induced GVBD of croaker oocytes in vitro which indicates that the maturational steroid is of ovarian origin. The finding that 17 alpha,20 beta,21-trihydroxy-4-pregnen-3-one (20 beta-S), a major steroid product of croaker oocytes during final oocyte maturation, is a potent inducer of GVBD suggests that it may function as a maturation-inducing steroid in this species.
 ...
PMID:Structure-activity relationships of steroids in inducing germinal vesicle breakdown of Atlantic croaker oocytes in vitro. 320 78

The biosynthesis of progesterone from [3H]pregnenolone was curvilinear over a 6 h time course in human placenta cytotrophoblasts and in human placenta choriocarcinoma cells (JEG-3 cells). Mass measurements determined independently by radioimmunoassay indicate that the progesterone synthesized by cytotrophoblasts (21.0 +/- 5.20 ng/6 h/mg protein) is substantially higher than that synthesized by the JEG-3 cells (4.48 +/- 0.56 ng/6 h/mg protein). Two tight binding inhibitors of 3 beta-hydroxysteroid dehydrogenase (2 alpha-cyanoprogesterone I and cyanoketone II), and a potent inhibitor of the microsomal conversion of pregnenolone to progesterone (2 alpha-bromo-5 alpha-androstan-3-one-17 beta-acetate III) were compared as inhibitors of progesterone synthesis in the two cell-types. Compounds I and II were very potent inhibitors yielding IC50 values of between 10 and 20 nM. At higher concentrations (100 nM - 1,000 nM) compound I promoted a complete cessation of progesterone synthesis which could be reversed by washing the cells free of inhibitor. By contrast compound III was ineffectual as an inhibitor yielding an IC50 value greater than 10 microM. This 1,000-fold difference in inhibitory potency suggests that 2 alpha-cyano-substituted steroids display an unusual capacity to inhibit progesterone biosynthesis and secretion in normal and transformed human cells.
Steroids
PMID:Inhibition of progesterone synthesis in normal and transformed human placental cells by tight binding inhibitors of 3 beta-hydroxysteroid dehydrogenase. 324 70

An X-ray crystal structure determination was performed on 2 beta,4 beta-cyclo-5 alpha- and rostane-3 alpha,17 beta-diol diacetate. The parent diol, but not its 3 beta-epimer, had been shown to be an effective inhibitor of a 3 beta-hydroxysteroid dehydrogenase.
Steroids
PMID:The crystal structure of 2 beta,4 beta-cyclo-5 alpha-androstane-3 alpha,17 beta-diol diacetate. 324 69

From PMSG-pretreated immature rats, dispersed ovarian cells were prepared with collagenase and DNase and incubated at 37 degrees C in McCoy's 5a medium under 95% air-5% CO2 atmosphere for 4 h. The activities of C17-C20 lyase measured in the 10,000 x g supernatant fluid of the cell homogenates decreased spontaneously with the lapse of time of the incubation. N,N'-Diphenyl-p-phenylenediamine (DPPD, an antioxidant) and actinomycin D inhibited the decrease most effectively. Cycloheximide was also an effective protector. Accordingly, the spontaneous decrease of the lyase activity was caused partly by an oxygen radical-mediated process and partly by a mechanism involving de novo synthesis of RNA and protein. Addition of hCG to the cells further decreased the lyase activity to about half of the control group at 4 h. DPPD itself did not affect the hCG-induced decrease of the lyase activity. However, actinomycin D and cycloheximide prevented the effect of hCG. These results indicate that de novo synthesis of RNA and protein is involved in the latter mechanism, while oxygen radical is not concerned in this process. The decrease of the enzyme activity by hCG during incubation is in agreement with the in vivo effect of hCG upon the lyase activity. On the contrary, at the end of incubation the activity of delta 5-3 beta-hydroxysteroid dehydrogenase (coupled with delta 5-delta 4 isomerase) was more than 89% of that before incubation, and the change of the enzyme activity according to the various treatments was less than 16%.
Steroids
PMID:In vitro decrease of lyase activity in rat ovarian cells during incubation: effect of hCG. 345 47

Flutamide (0.5 mM) decreased in vitro the activity of NADH-5 alpha-reductase (substrate testosterone) in liver homogenate of male and female rats, whereas no change of activity of NADPH-5 alpha-reductase was observed. NADH- and NADPH-5 beta-reductase activity increased only in liver of female, but not of male rats. NAD+-3 beta-hydroxysteroid dehydrogenase and NAD+-3 alpha-hydroxysteroid dehydrogenase (substrate 5 alpha-dihydro-testosterone) in liver homogenate from female rats were inhibited by flutamide (0.5 mM), whereas the activity of NADP+-3 alpha-hydroxysteroid dehydrogenase (substrate 5 alpha-dihydrotestosterone) and of NAD+-3 alpha-hydroxysteroid dehydrogenase (substrate 5 beta-dihydrotestosterone) increased in presence of flutamide. The activity of NADH- and NADPH-5 alpha-reductase decreased after flutamide administration to female rats at a dose of 5 mg per day for 7 days.
Steroids 1987 Jun
PMID:Effect of flutamide on 5 alpha-reductases, 5 beta-reductases, and 3-hydroxysteroid dehydrogenases in rat liver. 348 96

A regulatory model of human placental progesterone synthesis is based on studies with isolated placental enzymes. Steroids causing a dose-dependent inhibition are listed in the standing order of their inhibitory potency (I50 (microM)/Ki value (microM)/type of inhibition: c = competitive and nc = non competitive). Cholesterol side chain cleavage enzyme (mitochondria): Mainly regulated by hydroxylated cholesterol derivates. No inhibition was observed by cholesterylesters and by other naturally occurring steroids tested. 5-ene-3 beta-hydroxysteroid dehydrogenase-isomerase (mitochondria): 6 beta-hydroxyprogesterone (nc), dehydroepiandrosterone (0.32/0.82/c), 20 alpha-dihydroprogesterone (0.38/-/nc), progesterone (0.46/-), estrone (0.56/0.1/c), estradiol (0.1/0.8/c), 17 alpha-hydroxyprogesterone (2.1/-/nc), 17 alpha-hydroxypregnenolone (0.4/-/c), dehydroepiandrosterone sulfate (2.5/-/c), cortisone (5.0/-), cortisol (100/-). 20 alpha-hydroxysteroid dehydrogenase (cytoplasmic): estrone (0.26/0.7/c), estradiol (0.28/0.9/c), pregnenolone (4.4/9.2/c), 5 alpha-pregnan-3 beta-ol-20-one (4.6/-/nc), estriol (5.1/11.5/c); dehydroepiandrosterone (7.2/14.0/c), 5 alpha-dihydrotestosterone (26.0/-/nc), progesterone (33.0/48.0/c), dehydroepiandrosterone sulfate (50.0/23.0/nc), and testosterone (59.0/63.0/c). An autoregulatory mechanism of placental progesterone synthesis is postulated which is in good agreement with data published by others proving that placental progesterone synthesis is independent of the endocrine organs of the mother and the fetus.
 ...
PMID:Regulation of human placental progesterone synthesis in vitro by naturally occurring steroids. 385 7

Ketoconazole (K) is an antifungal imidazole derivative which has been shown to be a potent inhibitor of testosterone (T) biosynthesis in rodents and humans. To study the effect of K on rat testicular steroidogenesis we measured the activities of five testicular microsomal steroidogenic enzymes in K-treated rats and controls. Thirty male adult rats were given either 2 mg K or water every 12 hours by mouth during 5 days. Mean testicular weight was similar in both groups of animals. The K-treated group had a T serum concentration of 83 +/- 14 ng/dL whereas it was 94 +/- 16 ng/dL in the control group (NS). The K-treated animals had decreased activities of the 3 beta-hydroxysteroid dehydrogenase (830 +/- 48 vs 2,245 +/- 109 pmol/mg protein/min, P less than 0.001), 17-hydroxylase (243 +/- 5 vs 676 +/- 17 pmol/mg protein/min, P less than 0.001), 17-ketosteroid reductase (31 +/- 2 vs 169 +/- 7 pmol/mg protein/min, P less than 0.001), and aromatase enzymes (92 +/- 6 vs 123 +/- 7 pmol/mg protein/min, P less than 0.01). The 17,20-desmolase activity was similar in both groups of animals (210 +/- 4 vs 171 +/- 18 pmol/mg protein/min). We conclude that K given orally to rats inhibits the activity of several testicular steroidogenic enzymes.
Steroids 1985 Jul
PMID:Effects of ketoconazole on rat testicular steroidogenic enzymatic activities. 387 79


1 2 3 4 5 Next >>